Mechanisms of cardiac valve failure and the development of tissue engineered heart valves

Meghana R K Helder, Robert D. Simari

Research output: Chapter in Book/Report/Conference proceedingChapter

Abstract

Calcification of the aortic valve results in valvular dysfunction and is an important cause of morbidity and mortality. Our understanding of the process of aortic valve calcification has changed from a passive wear and tear process to that of an actively regulated process with known molecular mediators. Prior to calcification of the valve, activated valvular interstitial cells coordinate maladaptive extracellular matrix remodeling of the leaflets. Bioprosthetic heart valves used to surgically replace stenotic aortic valves have excellent hemodynamic profiles and are anti-thrombogenic. However, they fail due to similar mechanisms as native aortic valves and thus durability is a limiting factor. Mechanical prostheses necessitate anticoagulation. Ideal heart valve substitutes would be non-thrombogenic, maintain excellent hemodynamics, but would be durable and may hold the promise of growth. The basics of tissue engineering include fabricating a scaffold onto which autologous cells may be incorporated. The cells then transform the scaffold to autologous tissue with the ability to function in its desired location in the body. Popular scaffolds are decellularized allografts or xenogeneic aortic valves as they have the complex structure of the aortic valve still intact. Recellularization with valvular endothelial cells has been successful but avenues for recellularizing valvular interstitial cells are still being pursued. Alternative methods for generating scaffolds include three dimensional bioprinting and electrospinning.

Original languageEnglish (US)
Title of host publicationCardiac Fibrosis and Heart Failure: Cause or Effect?
PublisherSpringer International Publishing
Pages419-431
Number of pages13
ISBN (Print)9783319174372, 9783319174365
DOIs
StatePublished - Jan 1 2015
Externally publishedYes

Fingerprint

Heart Valves
Aortic Valve
Scaffolds
Heart Failure
Hemodynamics
Tissue
Bioprinting
Endothelial cells
Electrospinning
Scaffolds (biology)
Prosthetics
Tissue engineering
Allografts
Durability
Tissue Engineering
Tears
Wear of materials
Prostheses and Implants
Extracellular Matrix
Endothelial Cells

Keywords

  • Aortic valve stenosis
  • Decellularization
  • Tissue engineering

ASJC Scopus subject areas

  • Biochemistry, Genetics and Molecular Biology(all)
  • Medicine(all)

Cite this

Helder, M. R. K., & Simari, R. D. (2015). Mechanisms of cardiac valve failure and the development of tissue engineered heart valves. In Cardiac Fibrosis and Heart Failure: Cause or Effect? (pp. 419-431). Springer International Publishing. https://doi.org/10.1007/978-3-319-17437-2_21

Mechanisms of cardiac valve failure and the development of tissue engineered heart valves. / Helder, Meghana R K; Simari, Robert D.

Cardiac Fibrosis and Heart Failure: Cause or Effect?. Springer International Publishing, 2015. p. 419-431.

Research output: Chapter in Book/Report/Conference proceedingChapter

Helder, MRK & Simari, RD 2015, Mechanisms of cardiac valve failure and the development of tissue engineered heart valves. in Cardiac Fibrosis and Heart Failure: Cause or Effect?. Springer International Publishing, pp. 419-431. https://doi.org/10.1007/978-3-319-17437-2_21
Helder MRK, Simari RD. Mechanisms of cardiac valve failure and the development of tissue engineered heart valves. In Cardiac Fibrosis and Heart Failure: Cause or Effect?. Springer International Publishing. 2015. p. 419-431 https://doi.org/10.1007/978-3-319-17437-2_21
Helder, Meghana R K ; Simari, Robert D. / Mechanisms of cardiac valve failure and the development of tissue engineered heart valves. Cardiac Fibrosis and Heart Failure: Cause or Effect?. Springer International Publishing, 2015. pp. 419-431
@inbook{02fe4df186764993b26ce87be9753d23,
title = "Mechanisms of cardiac valve failure and the development of tissue engineered heart valves",
abstract = "Calcification of the aortic valve results in valvular dysfunction and is an important cause of morbidity and mortality. Our understanding of the process of aortic valve calcification has changed from a passive wear and tear process to that of an actively regulated process with known molecular mediators. Prior to calcification of the valve, activated valvular interstitial cells coordinate maladaptive extracellular matrix remodeling of the leaflets. Bioprosthetic heart valves used to surgically replace stenotic aortic valves have excellent hemodynamic profiles and are anti-thrombogenic. However, they fail due to similar mechanisms as native aortic valves and thus durability is a limiting factor. Mechanical prostheses necessitate anticoagulation. Ideal heart valve substitutes would be non-thrombogenic, maintain excellent hemodynamics, but would be durable and may hold the promise of growth. The basics of tissue engineering include fabricating a scaffold onto which autologous cells may be incorporated. The cells then transform the scaffold to autologous tissue with the ability to function in its desired location in the body. Popular scaffolds are decellularized allografts or xenogeneic aortic valves as they have the complex structure of the aortic valve still intact. Recellularization with valvular endothelial cells has been successful but avenues for recellularizing valvular interstitial cells are still being pursued. Alternative methods for generating scaffolds include three dimensional bioprinting and electrospinning.",
keywords = "Aortic valve stenosis, Decellularization, Tissue engineering",
author = "Helder, {Meghana R K} and Simari, {Robert D.}",
year = "2015",
month = "1",
day = "1",
doi = "10.1007/978-3-319-17437-2_21",
language = "English (US)",
isbn = "9783319174372",
pages = "419--431",
booktitle = "Cardiac Fibrosis and Heart Failure: Cause or Effect?",
publisher = "Springer International Publishing",

}

TY - CHAP

T1 - Mechanisms of cardiac valve failure and the development of tissue engineered heart valves

AU - Helder, Meghana R K

AU - Simari, Robert D.

PY - 2015/1/1

Y1 - 2015/1/1

N2 - Calcification of the aortic valve results in valvular dysfunction and is an important cause of morbidity and mortality. Our understanding of the process of aortic valve calcification has changed from a passive wear and tear process to that of an actively regulated process with known molecular mediators. Prior to calcification of the valve, activated valvular interstitial cells coordinate maladaptive extracellular matrix remodeling of the leaflets. Bioprosthetic heart valves used to surgically replace stenotic aortic valves have excellent hemodynamic profiles and are anti-thrombogenic. However, they fail due to similar mechanisms as native aortic valves and thus durability is a limiting factor. Mechanical prostheses necessitate anticoagulation. Ideal heart valve substitutes would be non-thrombogenic, maintain excellent hemodynamics, but would be durable and may hold the promise of growth. The basics of tissue engineering include fabricating a scaffold onto which autologous cells may be incorporated. The cells then transform the scaffold to autologous tissue with the ability to function in its desired location in the body. Popular scaffolds are decellularized allografts or xenogeneic aortic valves as they have the complex structure of the aortic valve still intact. Recellularization with valvular endothelial cells has been successful but avenues for recellularizing valvular interstitial cells are still being pursued. Alternative methods for generating scaffolds include three dimensional bioprinting and electrospinning.

AB - Calcification of the aortic valve results in valvular dysfunction and is an important cause of morbidity and mortality. Our understanding of the process of aortic valve calcification has changed from a passive wear and tear process to that of an actively regulated process with known molecular mediators. Prior to calcification of the valve, activated valvular interstitial cells coordinate maladaptive extracellular matrix remodeling of the leaflets. Bioprosthetic heart valves used to surgically replace stenotic aortic valves have excellent hemodynamic profiles and are anti-thrombogenic. However, they fail due to similar mechanisms as native aortic valves and thus durability is a limiting factor. Mechanical prostheses necessitate anticoagulation. Ideal heart valve substitutes would be non-thrombogenic, maintain excellent hemodynamics, but would be durable and may hold the promise of growth. The basics of tissue engineering include fabricating a scaffold onto which autologous cells may be incorporated. The cells then transform the scaffold to autologous tissue with the ability to function in its desired location in the body. Popular scaffolds are decellularized allografts or xenogeneic aortic valves as they have the complex structure of the aortic valve still intact. Recellularization with valvular endothelial cells has been successful but avenues for recellularizing valvular interstitial cells are still being pursued. Alternative methods for generating scaffolds include three dimensional bioprinting and electrospinning.

KW - Aortic valve stenosis

KW - Decellularization

KW - Tissue engineering

UR - http://www.scopus.com/inward/record.url?scp=84943369176&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84943369176&partnerID=8YFLogxK

U2 - 10.1007/978-3-319-17437-2_21

DO - 10.1007/978-3-319-17437-2_21

M3 - Chapter

AN - SCOPUS:84943369176

SN - 9783319174372

SN - 9783319174365

SP - 419

EP - 431

BT - Cardiac Fibrosis and Heart Failure: Cause or Effect?

PB - Springer International Publishing

ER -